In addition, 10–30% of FRDA patients develop overt diabetes and 30% have impaired glucose tolerance, which can result from lack of insulin secretion by the insulin-producing ß cells in the pancreas, insulin resistance in muscle, liver and fat, or from a combination of both [8]. The gene discussed is INS; the disease is Impaired glucose tolerance.